Furthermore, Borroni and co-authors subsequently developed a diagnostic algorithm that integrated the CSF tau ratio with midbrain-to-pons atrophy, achieving a high sensitivity of 94.2% and a specificity of 84.0% in differentiating PSP from CBD and FTD [26]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.